Brevan Howard Capital Management LP Has $530,000 Stock Holdings in Encompass Health Co. (NYSE:EHC)

Brevan Howard Capital Management LP trimmed its holdings in shares of Encompass Health Co. (NYSE:EHC - Free Report) by 40.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,742 shares of the company's stock after selling 3,864 shares during the quarter. Brevan Howard Capital Management LP's holdings in Encompass Health were worth $530,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. MassMutual Private Wealth & Trust FSB lifted its stake in shares of Encompass Health by 87.8% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company's stock valued at $27,000 after purchasing an additional 137 shares during the last quarter. Transce3nd LLC acquired a new stake in shares of Encompass Health during the 4th quarter worth about $40,000. CBIZ Investment Advisory Services LLC raised its position in shares of Encompass Health by 38.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company's stock worth $42,000 after acquiring an additional 127 shares in the last quarter. Tompkins Financial Corp acquired a new position in shares of Encompass Health in the fourth quarter valued at approximately $46,000. Finally, V Square Quantitative Management LLC boosted its stake in shares of Encompass Health by 43.8% in the fourth quarter. V Square Quantitative Management LLC now owns 581 shares of the company's stock valued at $54,000 after buying an additional 177 shares in the last quarter. 97.25% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research analysts have issued reports on the stock. Barclays upped their target price on shares of Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a report on Friday, April 25th. William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Royal Bank of Canada upped their price target on shares of Encompass Health from $110.00 to $125.00 and gave the stock an "outperform" rating in a research report on Monday, April 28th. KeyCorp upped their price objective on Encompass Health from $120.00 to $122.00 and gave the company an "overweight" rating in a report on Friday, April 25th. Finally, Truist Financial reissued a "buy" rating and set a $135.00 target price (up from $116.00) on shares of Encompass Health in a research note on Monday, April 28th. Nine analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus price target of $120.86.

Insider Transactions at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of the stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $98.29, for a total transaction of $495,578.18. Following the completion of the transaction, the chief accounting officer now directly owns 69,164 shares in the company, valued at $6,798,129.56. This represents a 6.79% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Elissa Joy Charbonneau sold 4,279 shares of the stock in a transaction on Tuesday, May 6th. The stock was sold at an average price of $116.61, for a total value of $498,974.19. Following the sale, the insider now owns 11,958 shares in the company, valued at $1,394,422.38. The trade was a 26.35% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 19,321 shares of company stock worth $2,142,452 over the last three months. 2.00% of the stock is currently owned by insiders.

Encompass Health Stock Up 0.8%

NYSE EHC traded up $0.96 on Tuesday, reaching $117.89. The stock had a trading volume of 604,840 shares, compared to its average volume of 687,765. The company has a market capitalization of $11.88 billion, a price-to-earnings ratio of 26.43, a P/E/G ratio of 2.31 and a beta of 0.91. The business has a 50 day moving average price of $103.77 and a 200 day moving average price of $100.16. Encompass Health Co. has a 1 year low of $82.74 and a 1 year high of $118.27. The company has a current ratio of 1.05, a quick ratio of 1.04 and a debt-to-equity ratio of 0.84.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings results on Thursday, April 24th. The company reported $1.37 EPS for the quarter, beating the consensus estimate of $1.19 by $0.18. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. The business had revenue of $1.46 billion during the quarter, compared to analysts' expectations of $1.43 billion. During the same quarter in the previous year, the business posted $1.12 EPS. The firm's quarterly revenue was up 10.6% compared to the same quarter last year. On average, analysts forecast that Encompass Health Co. will post 4.8 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be issued a dividend of $0.17 per share. The ex-dividend date is Tuesday, July 1st. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.58%. Encompass Health's dividend payout ratio (DPR) is presently 14.05%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.